|
|
Dry stabilized microemulsified omega-three acid-containing oils
The marine animal oil to be microemulsified may be derived from any desired marine animal source. Among the marine animal oils particularly contemplated for use are ...
|
|
|
Anti-ulcer composition
OF THE INVENTION The present invention provides an improved composition for ulcer curative/ulcer therapy agents capable of forming an ulcer-adherent protective complex, ...
|
|
|
Pediatric effervescent dosage form
OF THE PREFERRED EMBODIMENT An oral dosage form according to one embodiment of the present invention is a tablet of a size and shape adapted for direct oral ...
|
|
|
Defoaming composition
OF THE INVENTION The preferred fluid, nonaqueous, antifoaming or defoaming compound prepared as a flowable granule used herein is simethicone and, more specifically, ...
|
|
|
Fire-resistant styrene polymer foams
OF THE INVENTION In accordance with the invention, a variety of expandable thermoplastic homopolymers and copolymers can be made to have reduced flammability. The ...
|
|
|
Tissue processing method
I claim: 1. A method of processing a tissue specimen, comprising the steps of suspending the specimen in condensing vapours of a volatile dehydrating agent, condensing ...
|
|
|
Flame retardant compositions derived from difunctional carboxylic acids containing a halogenated thiophere ring and methods for their preparation
OF THE INVENTION The flame-retardant polyesters of this invention are derived, at least in part, from mono- or dihalogenated thiophene dicarboxylic acids. The ...
|
|
|
Radioactive scanning agents with stabilizer
OF THE INVENTION This invention is based on the discovery that gentisyl alcohol and its phenolate salts and esters (all hereinafter "gentisols") can be utilized to ...
|
|
|
Homocysteine thiolactone perchlorate as a tumor promotor
I claim: 1. A method of promoting the growth of malignant tumors in laboratory animals such as mice and rabbits which comprises utilizing intraperitoneally an effective ...
|
|
|
Time-release
We claim: 1. A tablet or dragee core for a time-release pharmaceutical composition, suitable for oral administration, which comprises as active ingredient 50 to 70% by ...
|